Exploring nitrofurantoin's renewed relevance in combating ESBL-producing Gram-negative bacteria in urinary tract infections amid the global AMR crisis.
Exploring nitrofurantoin's effectiveness against ESBL-producing E. coli and Klebsiella pneumoniae in uncomplicated UTIs